BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36912221)

  • 1. Modern treatment of sinonasal undifferentiated carcinoma.
    Neo WL; Hanna EY; Kiong KL
    Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):89-93. PubMed ID: 36912221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
    Kuo P; Manes RP; Schwam ZG; Judson BL
    Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
    Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
    J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of multi-modality therapies in sinonasal undifferentiated carcinoma-A timely update.
    See ASY; Chu C; Lim ICZY; Tan BKJ; Ang SXQ; Xu S; Teo NWY; Charn TC
    Clin Otolaryngol; 2024 Jan; 49(1):29-40. PubMed ID: 37859617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
    Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
    Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinonasal Undifferentiated Carcinoma.
    Abdelmeguid AS; Bell D; Hanna EY
    Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck.
    Yoshida E; Aouad R; Fragoso R; Farwell DG; Gandour-Edwards R; Donald PJ; Chen AM
    Am J Otolaryngol; 2013; 34(6):658-63. PubMed ID: 23993024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis.
    Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D
    Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinonasal undifferentiated carcinoma: an update.
    Enepekides DJ
    Curr Opin Otolaryngol Head Neck Surg; 2005 Aug; 13(4):222-5. PubMed ID: 16012246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinonasal undifferentiated carcinoma: Institutional trend toward induction chemotherapy followed by definitive chemoradiation.
    London NR; Mohyeldin A; Daoud G; Gamez ME; Blakaj D; Bonomi M; Prevedello DM; Carrau RL
    Head Neck; 2020 Nov; 42(11):3197-3205. PubMed ID: 32681692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Induction Therapy for Sinonasal Cancers.
    Kong KA; Thorp BD; Sheth SH
    Curr Treat Options Oncol; 2023 Mar; 24(3):162-169. PubMed ID: 36696082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma.
    Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY
    Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multimodality approach to sinonasal undifferentiated carcinoma: a single institute experience.
    Bhasker S; Mallick S; Benson R; Bhanuprasad V; Sharma A; Thakar A
    J Laryngol Otol; 2017 Jan; 131(1):19-25. PubMed ID: 27938440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment modalities in sinonasal undifferentiated carcinoma: an analysis from the national cancer database.
    Khan MN; Konuthula N; Parasher A; Genden EM; Miles BA; Govindaraj S; Iloreta AM
    Int Forum Allergy Rhinol; 2017 Feb; 7(2):205-210. PubMed ID: 27717204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.
    Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F
    J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognostic factors of sinonasal undifferentiated carcinoma: a multicenter study.
    de Bonnecaze G; Verillaud B; Chaltiel L; Fierens S; Chapelier M; Rumeau C; Malard O; Gavid M; Dufour X; Righini C; Uro-Coste E; Rives M; Bach C; Baujat B; Janot F; de Gabory L; Vergez S
    Int Forum Allergy Rhinol; 2018 Sep; 8(9):1065-1072. PubMed ID: 29935059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.
    Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A
    Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature.
    Zielinski V; Laban S; Tribius S; Schafhausen P; Veldhoen S; Knecht R; Clauditz T; Muenscher A
    Ear Nose Throat J; 2016 Jan; 95(1):23-8. PubMed ID: 26829682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
    Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
    Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncology for the rhinologist.
    Tam K; Dunn LA; Cohen MA
    Curr Opin Otolaryngol Head Neck Surg; 2024 Feb; 32(1):14-19. PubMed ID: 38116847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.